Share
359 Posts.
lightbulb Created with Sketch. 193
clock Created with Sketch. 05/06/25
14:58
Share
Originally posted by Silverchair:
↑
So it is no longer if, but when and how? ". For the drugs place in dermatology offices? This is also what I think many shareholders have long believed anyway. PW has pointed out quite a few times in the past that the FDA is primarily concerned with safety over efficacy. Clinuvel's drug is already FDA, EMA approved with years of solid data backing safety and the photos we have seen from patients who have received Scenesse for Vitiligo show dramatic proof of efficacy. Yesterday's ASX release made mention of this safety via their unique method of STEM CELL stimulation to rapidly repigment skin in contrast to other methods which are slower and silence the immune system to achieve any pigmentation. Then there was further positive news about the 'spontaneous repigmentation' some patients achieved after therapy which also sounds very positive.
Expand
Hey Silver..I'm 50/50 as to whether you're legit or not. I'll tell you this...these f*s have another 6-18 months of games to play. You may or may not be part of the shenanigans, but when the lid blows off, I hope to buy you a beer before we kill some of the plants.
(20min delay)